SoundHound AI, Inc. (NASDAQ: SOUN) closed its last trading session at $7.22, having gained 17.6% over the prior four weeks, with analysts suggesting further upside remains.
The mean Wall Street price target for SOUN stands at $11.57, implying a potential gain of approximately 60.3% from current price levels.
That consensus figure is drawn from seven individual short-term price targets, which carry a standard deviation of $3.21, reflecting a notable spread in analyst expectations.
The most conservative estimate places the stock at $7.00, representing a modest 3.1% decline, while the most bullish projection calls for a 121.6% surge to $16.00.
Standard deviation is a critical metric for evaluating analyst consensus, as a tighter clustering of targets generally signals stronger agreement on both direction and magnitude of price movement.
Researchers at multiple universities have found that price targets frequently mislead investors, with empirical evidence suggesting they rarely reflect where a stock’s price is actually headed.
Analysts are often incentivized to set optimistic price targets to generate interest in companies their firms have existing or prospective business relationships with, which can inflate consensus figures.
Beyond price targets, there is a separate and arguably stronger signal building for SOUN in the form of upward earnings estimate revisions from analysts covering the stock.
Over the last 30 days, the Zacks Consensus Estimate for SOUN’s current fiscal year has increased by 26.5%, driven by four upward revisions and no negative revisions during that period.
Empirical research has consistently demonstrated a strong correlation between positive trends in earnings estimate revisions and near-term stock price performance, lending credibility to the bullish case.
SOUN currently holds a Zacks Rank of number 2, categorized as a Buy, placing it within the top 20% of more than 4,000 stocks ranked across four earnings estimate-related factors.
Zacks notes that its ranking system carries an externally audited track record, positioning the Buy designation as a more reliable signal of near-term upside than analyst price targets alone.
Investors are advised to treat consensus price targets with skepticism as standalone indicators, while recognizing that the direction they imply, when paired with improving earnings estimates, can still serve as a useful research starting point.
